Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lime Therapeutics has developed a breakthrough LipidSense™ platform to rapidly identify novel targets and create drugs that modulate aberrant lipid metabolism. The company’s approach enables the discovery of precision medicines for cancers, metabolic disorders, lysosomal storage diseases, and neurodegenerative conditions. As of 2024, programs are preclinical with no reported clinical trial results yet.[1][2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lime Therapeutics.